MAIA Biotechnology, Inc.: MAIA Biotechnology to Present Anti

MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs ("MAIA"), today announced that it has been selected to conduct an

Related Keywords

Solna , Stockholm , Sweden , Dallas , Texas , United States , Chicago , Illinois , University Of Texas , Stephanie Carrington , Sergei Gryaznov , Jerryw Shay , Sergeim Gryaznov , International Round Table On Nucleosides , Southwestern Medical Center , Biotechnology Inc , Maia Biotechnology Inc , International Round Table , Round Table , Nucleic Acids , Chief Scientific Officer , Vlad Vitoc , Chief Executive , Driven Telomeric , Cancer Cells Leads , Efficient Induction , Adoptive Immune , Karolinska Institutet Campus Solna , Looking Statements , Maia , Biotechnology , Present , Anticancer , Ohio , Platform , Nternational , Hound , Table , Nucleosides , Nucleotides , Nucleic , Acids ,